ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study
Anti-Cancer Drugs
◽
10.1097/cad.0b013e3280126603
◽
2007
◽
Vol 18
(4)
◽
pp. 487-491
◽
Cited By ~ 28
Author(s):
Chia-Chi Lin
◽
Chih-Hung Hsu
◽
Chao-Yuan Huang
◽
Hsiao-Yi Keng
◽
Yu-Chieh Tsai
◽
...
Keyword(s):
Urothelial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Metastatic Urothelial Carcinoma
Download Full-text
Related Documents
Cited By
References
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: A phase II study of the SUOC group
Cancer Science
◽
10.1111/j.1349-7006.2011.01909.x
◽
2011
◽
Vol 102
(6)
◽
pp. 1171-1175
◽
Cited By ~ 20
Author(s):
Hiroshi Kitamura
◽
Keisuke Taguchi
◽
Yasuharu Kunishima
◽
Masahiro Yanase
◽
Atsushi Takahashi
◽
...
Keyword(s):
Urothelial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Metastatic Urothelial Carcinoma
Download Full-text
A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma
Clinical Genitourinary Cancer
◽
10.1016/j.clgc.2015.09.008
◽
2016
◽
Vol 14
(1)
◽
pp. 76-81
◽
Cited By ~ 7
Author(s):
Young Saing Kim
◽
Soon Il Lee
◽
Se Hoon Park
◽
Silvia Park
◽
In Gyu Hwang
◽
...
Keyword(s):
Urothelial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Second Line Chemotherapy
◽
Weekly Docetaxel
◽
Metastatic Urothelial Carcinoma
◽
Line Chemotherapy
Download Full-text
A Phase II Study of Docetaxel and Oxaliplatin for Second-Line Treatment of Urothelial Carcinoma
Chemotherapy
◽
10.1159/000230695
◽
2009
◽
Vol 55
(5)
◽
pp. 321-326
◽
Cited By ~ 11
Author(s):
Sandy Srinivas
◽
Lauren C. Harshman
Keyword(s):
Urothelial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
Download Full-text
A phase II study of single-agent nab-paclitaxel as second-line therapy in patients with metastatic urothelial carcinoma.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.tps231
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. TPS231-TPS231
◽
Cited By ~ 5
Author(s):
S. S. Sridhar
◽
C. M. Canil
◽
S. D. Mukherjee
◽
E. Winquist
◽
C. Elser
◽
...
Keyword(s):
Urothelial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Single Agent
◽
Second Line
◽
Second Line Therapy
◽
Line Therapy
◽
Metastatic Urothelial Carcinoma
Download Full-text
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature
Journal of Neurosurgical Sciences
◽
10.23736/s0390-5616.16.03874-1
◽
2019
◽
Vol 63
(4)
◽
Cited By ~ 7
Author(s):
Salvatore Grisanti
◽
Vittorio D. Ferrari
◽
Michela Buglione
◽
Giorgio M. Agazzi
◽
Roberto Liserre
◽
...
Keyword(s):
Systematic Review
◽
Phase Ii
◽
Phase Ii Study
◽
Recurrent Glioblastoma
◽
Line Treatment
◽
Second Line
◽
Review Of Literature
Download Full-text
Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: A phase II study
Urologic Oncology Seminars and Original Investigations
◽
10.1016/j.urolonc.2005.06.013
◽
2005
◽
Vol 23
(5)
◽
pp. 381-382
Author(s):
Donald L. Trump
Keyword(s):
Urothelial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Line Treatment
◽
First Line
◽
Advanced Urothelial Carcinoma
◽
First Line Treatment
Download Full-text
21LBA Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)
European Journal of Cancer
◽
10.1016/s0959-8049(16)31942-6
◽
2015
◽
Vol 51
◽
pp. S720
◽
Cited By ~ 8
Author(s):
J. Rosenberg
◽
D. Petrylak
◽
O. Abidoye
◽
M.S. Van der Heijden
◽
J. Hofman-Censits
◽
...
Keyword(s):
Urothelial Carcinoma
◽
Phase Ii
◽
Phase Ii Study
◽
Locally Advanced
◽
Multicenter Phase
◽
Metastatic Urothelial Carcinoma
Download Full-text
P-524 Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: Phase II study
Lung Cancer
◽
10.1016/s0169-5002(05)81017-7
◽
2005
◽
Vol 49
◽
pp. S255
Author(s):
S. Lee
◽
E. Lee
◽
H. Jeong
◽
S. Lee
◽
J. Kim
◽
...
Keyword(s):
Phase Ii
◽
Lung Carcinoma
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Cell Lung Carcinoma
◽
Nonsmall Cell Lung Carcinoma
Download Full-text
Randomized Phase II Study of PARP Inhibitor Veliparib with Modified FOLFIRI versus FOLFIRI as Second Line Treatment of Metastatic Pancreatic Cancer: SWOG S1513
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-21-1789
◽
2021
◽
pp. clincanres.1789.2021
Author(s):
E. Gabriela Chiorean
◽
Katherine A Guthrie
◽
Philip A Philip
◽
Elizabeth M. Swisher
◽
Florencia Jalikis
◽
...
Keyword(s):
Pancreatic Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Parp Inhibitor
◽
Metastatic Pancreatic Cancer
◽
Line Treatment
◽
Second Line
◽
Randomized Phase Ii
Download Full-text
Phase II study of evofosfamide (TH-302) monotherapy as a second-line treatment in advanced biliary tract cancer
Annals of Oncology
◽
10.1093/annonc/mdy282.142
◽
2018
◽
Vol 29
◽
pp. viii259
Author(s):
J.S. Yoon
◽
K.-H. Lee
◽
G.J. Cheon
◽
Y.-J. Bang
◽
D.-Y. Oh
Keyword(s):
Biliary Tract
◽
Phase Ii
◽
Biliary Tract Cancer
◽
Phase Ii Study
◽
Line Treatment
◽
Second Line
◽
Tract Cancer
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close